Larvol Delta - Bambusa-Therapeutics-Completes-Patient-Enrollment-in-the-Phase-1b2a-Trial-Evaluating-BBT001-as-a-Treatment-for-Atopic-Dermatitis

BBT001 - Bambusa Therapeutics

https://www.prnewswire.com/news-releases/bambusa-therapeutics-completes-patient-enrollment-in-the-phase-1b2a-trial-evaluating-bbt001-as-a-treatment-for-atopic-dermatitis-302757932.html

Apr 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next